Renewable Design for Covid - SARS-CoV-2 & Influenza A/B Multiplex Real-Time PCR Kit – Yinye
Renewable Design for Covid - SARS-CoV-2 & Influenza A/B Multiplex Real-Time PCR Kit – Yinye Detail:
REF | 510010 | Specification | 96 Tests/Box |
Detection principle | PCR | Specimens | Nasal / Nasopharyngeal swab / Oropharyngeal swab |
Intended Use |
StrongStep® SARS-CoV-2 & Influenza A/B Multiplex Real-Time PCR Kit is intended for simultaneous qualitative detection and differentiation of SARS-CoV-2,Influenza A virus and Influenza B virus RNA in healthcare provider-collected nasal and nasopharyngeal swab or oropharyngeal swab specimens and self-collected nasal or oropharyngeal swab specimens(collected in a healthcare setting with instruction by a healthcare provider) from individuals suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider. |
The kit is intended for use by laboratory trained personnel
StrongStep® SARS-CoV-2 & Influenza A/B Multiplex Real-Time PCR Kit is intended for simultaneous qualitative detection and differentiation of SARS-CoV-2,Influenza A virus and Influenza B virus RNA in healthcare provider-collected nasal and nasopharyngeal swab or oropharyngeal swab specimens and self-collected nasal or oropharyngeal swab specimens(collected in a healthcare setting with instruction by a healthcare provider) from individuals suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider. RNA from SARS-CoV-2, influenza A, and influenza B is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2, influenza A, and/or influenza B RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Negative results do not preclude infection from SARS-CoV-2, influenza A, and/or influenza B and should not be used as the sole basis for treatment or other patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information. StrongStep® SARS-CoV-2 & Influenza A/B Multiplex Real-Time PCR Kit is intended for use by qualified clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR assays and in vitro diagnostic procedures.
Product detail pictures:
Related Product Guide:
Assume full accountability to fulfill all demands of our purchasers; attain continual advancements by marketing the advancement of our clientele; grow to be the final permanent cooperative partner of purchasers and maximize the interests of purchasers for Renewable Design for Covid - SARS-CoV-2 & Influenza A/B Multiplex Real-Time PCR Kit – Yinye , The product will supply to all over the world, such as: Mauritius, Morocco, Croatia, We have been sincerely looking forward to cooperate with customers all over the world. We believe we can satisfy you with our high-quality products and solutions and perfect service . We also warmly welcome customers to visit our company and purchase our products.
By Margaret from Switzerland - 2018.10.31 10:02
The sales manager is very patient, we communicated about three days before we decided to cooperate, finally, we are very satisfied with this cooperation!
By Elizabeth from Cologne - 2018.02.21 12:14